| # | Drug | Count |
|---|---|---|
| 0 | CLONAZEPAM | 10 |
| 1 | OLANZAPINE | 10 |
| 2 | VALPROIC ACID | 10 |
| 3 | QUETIAPINE | 5 |
| 4 | RISPERIDONE | 5 |
| 5 | NIVOLUMAB | 4 |
| 6 | PREDNISONE | 4 |
| 7 | BLINATUMOMAB | 3 |
| 8 | CYTARABINE | 3 |
| 9 | FLUDARABINE PHOSPHATE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GEMTUZUMAB OZOGAMICIN | 3 | 0.0008 |
| 1 | VALPROIC ACID | 10 | 0.0003 |
| 2 | BLINATUMOMAB | 3 | 0.0003 |
| 3 | OLANZAPINE | 10 | 0.0001 |
| 4 | ENFORTUMAB VEDOTIN | 1 | 0.0001 |
| 5 | BINIMETINIB | 1 | 0.0001 |
| 6 | ENCORAFENIB | 1 | 0.0001 |
| 7 | FLUDARABINE PHOSPHATE | 3 | 0.0001 |
| 8 | REMDESIVIR | 1 | 0.0001 |
| 9 | RISPERIDONE | 5 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD33-directed Immunoconjugate [EPC] | 3 | 0.0008 |
| 1 | Recombinant Human Growth Hormone [EPC] | 3 | 0.0001 |
| 2 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 3 | BCL-2 Inhibitor [EPC] | 3 | 0.0000 |
| 4 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 5 | Mood Stabilizer [EPC] | 10 | 0.0000 |
| 6 | Anti-epileptic Agent [EPC] | 10 | 0.0000 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 4 | 0.0000 |
| 8 | Atypical Antipsychotic [EPC] | 17 | 0.0000 |
| 9 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 3 | 0.0000 |